Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.61 |
| ▸ | NOS1 | P29475 | 1/20 | 0.61 |
| ▸ | NOS2 | P35228 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.40 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | CDC7 | O00311 | 1/20 | 0.38 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.38 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11563922 | 0.98 | NOS3 (0.59) | NOS3NOS1NOS2CYP1A2POLB | |
| Dimethylamine SCHEMBL7744073 | 0.93 | NOS3 (0.55) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL13337725 | 0.84 | NOS3 (0.55) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL14470239 | 0.84 | NOS3 (0.55) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL16775566 | 0.84 | CYP1A2 (0.47) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL15200880 | 0.84 | NOS3 (0.61) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL1654460 | 0.84 | LOXL2 (0.55) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL10066451 | 0.84 | NOS3 (0.55) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL5115940 | 0.84 | NOS3 (0.55) | NOS3NOS1NOS2CYP1A2POLB | |
| SCHEMBL2935815 | 0.84 | RECQL (0.55) | NOS3NOS1NOS2CYP1A2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110862473-A | Catalyst for olefin polymerization reaction, preparation method and composite catalyst | 中国石油化工股份有限公司 | 2020-03-06 | — | — | CN | claimed |
| US-9796800-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2017-10-24 | — | — | US | claimed |
| US-20160108153-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2016-04-21 | — | — | US | claimed |
| US-9249244-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2016-02-02 | — | — | US | claimed |
| EP-2619233-A1 | PROCESS FOR PRODUCING POLYDIENES | Bridgestone Corporation (JP) | 2013-07-31 | — | — | EP | claimed |
| WO-2012040026-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | WO | claimed |
| US-4150993-A | AMINEBORANE COMPOUND | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1979-04-24 | — | — | US | claimed |
| US-12559458-B2 | Co-crystals or salts of psilocin and methods of treatment therewith | Reset Pharmaceuticals, Inc. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4486448-A1 | CO-CRYSTALS OR SALTS COMPRISING PSILOCIN | Reset Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| US-20240383849-A1 | CO-CRYSTAL OR SALT | Reset Pharmaceuticals, Inc. | 2024-11-21 | — | — | US | disclosed |
| CN-118871423-A | Co-crystals or salts comprising xylometacin | 雷塞特制药股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-12060328-B2 | Co-crystals or salts of psilocybin and methods of treatment therewith | Reset Pharmaceuticals, Inc. (US) | 2024-08-13 | — | — | US | disclosed |
| WO-2023220137-A1 | PYRAZINE DERIVATIVES AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| US-4740320-A | REACTION OF NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPONENT, KETONE OR ALDEHYDE, AMINE OR POLYAMINE | THE DOW CHEMICAL COMPANY (US) | 1988-04-26 | — | — | US | disclosed |
| US-4725373-A | CORROSION RESISTANCE FOR METAL TOOLS AND EQUIPMENT USED IN OIL AND GAS WELLS | THE DOW CHEMICAL COMPANY (US) | 1988-02-16 | — | — | US | disclosed |
| US-4724003-A | Asphalt compositions containing anti-stripping additives prepared from hydrocarbyl substituted nitrogen-containing aromatic heterocyclic compounds, aldehydes or ketones and amines | THE DOW CHEMICAL COMPANY (US) | 1988-02-09 | — | — | US | disclosed |
| US-4676834-A | Novel compositions prepared from methyl substituted nitrogen-containing aromatic heterocyclic compounds and an aldehyde or ketone | THE DOW CHEMICAL COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
| US-4157262-A | Intensification of photographic silver images by physical development and improvement in physical developer solution for use therein | FUJI PHOTO FILM CO., LTD. (JP) | 1979-06-05 | — | — | US | disclosed |
| US-4150993-A | AMINEBORANE COMPOUND | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1979-04-24 | — | — | US | disclosed |
| US-4042602-A | Synthesis of dideoxyzearalane and related compounds | IMC CHEMICAL GROUP, INC. (US) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383849-A1 | CO-CRYSTAL OR SALT | SLC6A3, SLC6A2, OPRK1 | NOS3 2442/4885NOS1 2402/4885NOS2 2632/4885 |
| US-12060328-B2 | Co-crystals or salts of psilocybin and methods of treatment therewith | SLC6A3, SLC6A2, HTR2B | NOS3 1608/4885NOS1 1813/4885NOS2 1594/4885 |
| US-12559458-B2 | Co-crystals or salts of psilocin and methods of treatment therewith | SLC6A2, SLC6A4, SLC6A3 | NOS3 3195/4885NOS1 3445/4885NOS2 3189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.